vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and Zurn Elkay Water Solutions Corp (ZWS). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $407.2M, roughly 1.3× Zurn Elkay Water Solutions Corp). Zurn Elkay Water Solutions Corp runs the higher net margin — 10.3% vs -12.3%, a 22.7% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 4.4%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Zurn Elkay Water Solutions Corp designs, manufactures, and distributes a wide range of water management and dispensing products, including commercial plumbing fixtures, drinking fountains, water filtration systems, and flow control components. It serves commercial, residential, industrial, and public infrastructure markets primarily across North America, with a focus on delivering sustainable, water-efficient solutions for diverse end-user needs.

GENI vs ZWS — Head-to-Head

Bigger by revenue
GENI
GENI
1.3× larger
GENI
$510.9M
$407.2M
ZWS
Higher net margin
ZWS
ZWS
22.7% more per $
ZWS
10.3%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
4.4%
ZWS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
ZWS
ZWS
Revenue
$510.9M
$407.2M
Net Profit
$-63.0M
$42.1M
Gross Margin
25.2%
44.4%
Operating Margin
-11.5%
14.8%
Net Margin
-12.3%
10.3%
Revenue YoY
9.8%
Net Profit YoY
15.7%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
ZWS
ZWS
Q4 25
$510.9M
$407.2M
Q3 25
$335.4M
$455.4M
Q2 25
$215.2M
$444.5M
Q1 25
$119.7M
$388.8M
Q4 24
$413.0M
$370.7M
Q3 24
$285.8M
$410.0M
Q2 24
$184.1M
$412.0M
Q1 24
$97.2M
$373.8M
Net Profit
GENI
GENI
ZWS
ZWS
Q4 25
$-63.0M
$42.1M
Q3 25
$61.8M
Q2 25
$-47.3M
$50.5M
Q1 25
$-25.5M
$43.6M
Q4 24
$-85.5M
$36.4M
Q3 24
$-47.1M
$43.5M
Q2 24
$-35.5M
$46.0M
Q1 24
$-25.2M
$34.3M
Gross Margin
GENI
GENI
ZWS
ZWS
Q4 25
25.2%
44.4%
Q3 25
24.2%
44.1%
Q2 25
19.1%
45.5%
Q1 25
10.7%
46.6%
Q4 24
16.7%
43.5%
Q3 24
20.5%
46.2%
Q2 24
18.6%
45.2%
Q1 24
9.8%
45.5%
Operating Margin
GENI
GENI
ZWS
ZWS
Q4 25
-11.5%
14.8%
Q3 25
-15.3%
17.0%
Q2 25
-21.0%
17.5%
Q1 25
-20.3%
16.3%
Q4 24
-18.0%
13.3%
Q3 24
-13.9%
17.1%
Q2 24
-16.8%
17.5%
Q1 24
-23.7%
14.2%
Net Margin
GENI
GENI
ZWS
ZWS
Q4 25
-12.3%
10.3%
Q3 25
13.6%
Q2 25
-22.0%
11.4%
Q1 25
-21.3%
11.2%
Q4 24
-20.7%
9.8%
Q3 24
-16.5%
10.6%
Q2 24
-19.3%
11.2%
Q1 24
-25.9%
9.2%
EPS (diluted)
GENI
GENI
ZWS
ZWS
Q4 25
$0.24
Q3 25
$0.36
Q2 25
$0.29
Q1 25
$0.26
Q4 24
$0.21
Q3 24
$0.25
Q2 24
$0.27
Q1 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
ZWS
ZWS
Cash + ST InvestmentsLiquidity on hand
$280.6M
$300.5M
Total DebtLower is stronger
$496.5M
Stockholders' EquityBook value
$724.5M
$1.6B
Total Assets
$1.1B
$2.7B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
ZWS
ZWS
Q4 25
$280.6M
$300.5M
Q3 25
$110.2M
$260.1M
Q2 25
$110.2M
$201.9M
Q1 25
$110.2M
$144.7M
Q4 24
$100.3M
$198.0M
Q3 24
$100.3M
$187.9M
Q2 24
$100.3M
$162.7M
Q1 24
$100.3M
$157.1M
Total Debt
GENI
GENI
ZWS
ZWS
Q4 25
$496.5M
Q3 25
$496.4M
Q2 25
$495.9M
Q1 25
$495.8M
Q4 24
$495.6M
Q3 24
$495.6M
Q2 24
$495.5M
Q1 24
$495.4M
Stockholders' Equity
GENI
GENI
ZWS
ZWS
Q4 25
$724.5M
$1.6B
Q3 25
$572.4M
$1.6B
Q2 25
$572.4M
$1.6B
Q1 25
$572.4M
$1.5B
Q4 24
$573.0M
$1.6B
Q3 24
$573.0M
$1.6B
Q2 24
$573.0M
$1.6B
Q1 24
$573.0M
$1.6B
Total Assets
GENI
GENI
ZWS
ZWS
Q4 25
$1.1B
$2.7B
Q3 25
$792.3M
$2.7B
Q2 25
$792.3M
$2.7B
Q1 25
$792.3M
$2.6B
Q4 24
$775.7M
$2.6B
Q3 24
$775.7M
$2.7B
Q2 24
$775.7M
$2.7B
Q1 24
$775.7M
$2.7B
Debt / Equity
GENI
GENI
ZWS
ZWS
Q4 25
0.31×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.32×
Q4 24
0.31×
Q3 24
0.31×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
ZWS
ZWS
Operating Cash FlowLast quarter
$81.9M
$91.7M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
2.18×
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
ZWS
ZWS
Q4 25
$81.9M
$91.7M
Q3 25
$-4.8M
$101.3M
Q2 25
$-1.2M
$110.6M
Q1 25
$-14.6M
$42.9M
Q4 24
$14.9M
$63.6M
Q3 24
$-9.2M
$90.9M
Q2 24
$85.1M
Q1 24
$53.9M
Free Cash Flow
GENI
GENI
ZWS
ZWS
Q4 25
$69.6M
Q3 25
$-14.2M
Q2 25
$-5.8M
Q1 25
$-16.0M
Q4 24
$11.3M
Q3 24
$-11.6M
Q2 24
Q1 24
FCF Margin
GENI
GENI
ZWS
ZWS
Q4 25
13.6%
Q3 25
-4.2%
Q2 25
-2.7%
Q1 25
-13.4%
Q4 24
2.7%
Q3 24
-4.1%
Q2 24
Q1 24
Capex Intensity
GENI
GENI
ZWS
ZWS
Q4 25
2.4%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
1.2%
Q4 24
0.9%
Q3 24
0.9%
Q2 24
Q1 24
Cash Conversion
GENI
GENI
ZWS
ZWS
Q4 25
2.18×
Q3 25
1.64×
Q2 25
2.19×
Q1 25
0.98×
Q4 24
1.75×
Q3 24
2.09×
Q2 24
1.85×
Q1 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons